000 | 01165 a2200313 4500 | ||
---|---|---|---|
005 | 20250517231703.0 | ||
264 | 0 | _c20190523 | |
008 | 201905s 0 0 eng d | ||
022 | _a1750-192X | ||
024 | 7 |
_a10.2217/epi-2017-0171 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMackin, Sarah-Jayne | |
245 | 0 | 0 |
_aComparison of DNMT1 inhibitors by methylome profiling identifies unique signature of 5-aza-2'deoxycytidine. _h[electronic resource] |
260 |
_bEpigenomics _c08 2018 |
||
300 |
_a1085-1101 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDNA (Cytosine-5-)-Methyltransferase 1 _xantagonists & inhibitors |
650 | 0 | 4 | _aDNA Methylation |
650 | 0 | 4 |
_aDecitabine _xpharmacology |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
700 | 1 | _aO'Neill, Karla M | |
700 | 1 | _aWalsh, Colum P | |
773 | 0 |
_tEpigenomics _gvol. 10 _gno. 8 _gp. 1085-1101 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/epi-2017-0171 _zAvailable from publisher's website |
999 |
_c28693567 _d28693567 |